Drug interactions of new antiretroviral drugs
Farmacia Hospitalaria (English Edition), ISSN: 2173-5085, Vol: 35, Issue: 1, Page: 36-43
2011
- 4Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures4
- Readers4
Review Description
A systematic review was made of the drug interactions of new antiretroviral drugs. In order to do this a search was made in Pubmed to find articles published from January 2007 to September 2009 and the full-text articles which contained information about new antiretroviral drugs were selected. This search was then complemented with information from the technical specifications of the drugs and consultations made on webpages specialized in antiretroviral interactions: www.interaccioneshiv.com and www.hiv-druginteractions.org. The information about the possible interactions of new antiretroviral drugs with one another and with the therapeutic groups which are most widely used in patients infected with the human immunodeficiency virus was analyzed. Se realiza una revisión sistemática sobre interacciones medicamentosas de los nuevos fármacos antirretrovirales. Para ello se realiza una búsqueda en Pubmed de artículos publicados entre enero de 2007 y septiembre de 2009 y se consideraron los artículos disponibles a texto completo que aportaban alguna información sobre los nuevos antirretrovirales. Esta búsqueda fue complementada a su vez con la información de las fichas técnicas de los productos y consultas en las páginas web específicas de interacciones de antirretrovirales: www.interaccioneshiv. com y www.hiv-druginteractions.org. Se analiza la información de las posibles interacciones de los nuevos antirretrovirales entre sí, y con los grupos terapéuticos más frecuentemente utilizados en pacientes con el virus de la inmunodeficiencia humana.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2173508511700077; http://dx.doi.org/10.1016/s2173-5085(11)70007-7; http://linkinghub.elsevier.com/retrieve/pii/S2173508511700077; http://api.elsevier.com/content/article/PII:S2173508511700077?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S2173508511700077?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S2173508511700077; http://dx.doi.org/10.1016/s2173-5085%2811%2970007-7; https://dx.doi.org/10.1016/s2173-5085%2811%2970007-7
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know